Novartis secures US$30m+ licence option from BioArctic

Alzheimer’s antibody Lecanemab launched in the EU

Mallia Aesthetics is about to launch MAL-838

Merck and mantro enter the foodtech market

Trump delays 250% tariffs on non-U.S. pharmaceuticals